Article Sidebar
Published:
Jun 14, 2017Article Details
Copyright remains in the Author’s name. The work is licensed under a Creative Commons Attribution - Noncommercial Works License. Authors are required to complete and sign an Author Agreement form that outlines Author and Publisher rights and terms of publication. The Agreement form should be uploaded along with other submissions files and any submission will be considered incomplete without it [forthcoming].
Material submitted for publication in the SAMJ is accepted provided it has not been published or submitted for publication elsewhere. Please inform the editorial team if the main findings of your paper have been presented at a conference and published in abstract form, to avoid copyright infringement. The SAMJ does not hold itself responsible for statements made by the authors.
Previously published images
If an image/figure has been previously published, permission to reproduce or alter it must be obtained by the authors from the original publisher and the figure legend must give full credit to the original source. This credit should be accompanied by a letter indicating that permission to reproduce the image has been granted to the author/s. This letter should be uploaded as a supplementary file during submission.
Main Article Content
The relationship between insight and psychosis in state patients with schizophrenia
Abstract
Method. 34 patients with schizophrenia were evaluated twice to determine their level of insight and psychopathology. The following factors were considered: duration of hospitalisation, duration of illness, age of onset of illness, and level of functioning before admission.
Results. Insight improved slightly over the 2-month period, showing weak correlation with psychopathology. Negative insight, insight regarding mental illness and the use of medication, and attribution of past illness were good.
Conclusion. Insight should be viewed as being multidimensional, with various factors influencir!g it. Level of insight plays an important role in the treatment programme of patients with schizophrenia.
